Atlas Trials

Supplementation With Conjugated Linoleic Acid (CLA) as Complementary Therapy in the Management of Type 2 Diabetes Mellitus (Women's Diabetes Study)

Clinical trial NCT01121471 · COMPLETED

Trial details

NCT number
NCT01121471
Sponsor
Ohio State University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2004-12-01
Primary completion
2006-11-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.